|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$45,330.00 |
2.39% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$44,032.82 |
2.33% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$42,037.51 |
2.22% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$41,602.50 |
2.20% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$41,188.10 |
2.18% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$41,312.70 |
2.18% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$40,505.14 |
2.14% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$40,009.90 |
2.11% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$39,646.02 |
2.09% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$39,601.57 |
2.09% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$39,295.68 |
2.08% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$38,997.15 |
2.06% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$38,937.45 |
2.06% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$38,732.70 |
2.05% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$38,593.24 |
2.04% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,590.56 |
2.04% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$38,592.42 |
2.04% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,442.33 |
2.03% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,373.66 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
173 |
$38,438.87 |
2.03% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$38,332.26 |
2.03% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$38,097.95 |
2.01% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$37,621.32 |
1.99% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$37,555.00 |
1.98% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$37,408.80 |
1.98% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$37,521.38 |
1.98% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$37,507.14 |
1.98% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$37,354.32 |
1.97% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$37,324.00 |
1.97% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$37,030.23 |
1.96% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$37,142.96 |
1.96% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$37,002.50 |
1.96% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$36,908.76 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$36,966.30 |
1.95% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$36,665.86 |
1.94% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$36,650.64 |
1.94% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$36,773.54 |
1.94% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$36,732.58 |
1.94% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,507.12 |
1.93% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$36,366.28 |
1.92% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,373.71 |
1.92% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$36,313.35 |
1.92% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,327.43 |
1.92% |
| Waters Corporation |
WAT |
941848103 |
121 |
$36,274.59 |
1.92% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$36,126.54 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$35,728.00 |
1.89% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$35,216.31 |
1.86% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$34,872.28 |
1.84% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$30,503.30 |
1.61% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$21,700.63 |
1.15% |
| US Dollar |
$USD |
|
7,539 |
$7,538.75 |
0.40% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|